About Magna
Magna is a venture capital firm founded in 2010. It is primarily based out of Seoul, South Korea. As of Aug 2026, Magna is an active investor, having invested in 56 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in South Korea based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series A round of ABLE Labs Overall, Magna portfolio has seen 22 IPOs and 2 acquisitions including key companies like D&D Pharmatech, Oncocross and Adbiotech. A lot of funds co-invest with Magna, with names like Shinhan Financial Group sharing a substantial percentage of its portfolio. Magna has team of 10 people including 5 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 1 more
Portfolio Soonicorns
Magna's List of Top Investments
Magna has a portfolio of 56 companies. Their most notable investments are in DeepX and CastingN.Their portfolio spans across and South Korea. They have invested in Life Sciences, High Tech, Enterprise Applications and 20 other sectors, across stages such as Series A, Seed and 1 more. Here is the list of top investments by Magna:1. WireBarley
Online platform for cross-border money transfer. It is a fintech company that provides a platform for cross-border payment transactions, enabling individuals and businesses to send and receive money globally. It provides a suite of solution for the user interface, mobile application and web systems. It also allows money transfer business to start businesses in their own countries providing infrastructure expenditure. It allows to plug into its platform and use the payment network.
Key facts about WireBarley
- Founded Year: 2016
- Location: Seoul (South Korea)
- Stage: Series B
- Total Funding till date: $16M
- Employee Count: 49 as on Jul 31, 2026
- Investors: Magna, DT&Investment and 7 Others
- Latest Funding Round: Series B, Sep 17, 2020, $*****
- Highlight: Editors' Pick
Developer of GLP-1-based therapeutics for metabolic disease treatment. It focuses on building on a robust foundation of proprietary peptide research and strategic collaborations. D&D Pharmatech is advancing a diverse pipeline of therapeutics for metabolic, fibrotic, and neurodegenerative diseases. The global biotech company’s umbrella structure comprises three U.S. subsidiaries, including Neuraly Inc, its clinical research arm responsible for conducting clinical trials for the company’s pipeline, including its dual agonist (GLP-1/glucagon) for metabolic dysfunction-associated steatohepatitis (MASH).
Key facts about D&D Pharmatech
- Founded Year: 2014
- Location: Seongnam-si (South Korea)
- Stage: Public
- Total Funding till date: $205M
- Employee Count: 60 as on Feb 28, 2026
- Investors: Octave Ventures, Magna and 10 Others
- Latest Funding Round: Post IPO, Jun 20, 2025, $*****
- Highlight: Public
3. DeepX
Developer of AI semiconductors, modules, and systems for edge computing applications. It offers AI chips engineered for integration into devices, AI modules with inference capabilities, and AI systems designed for performance and efficiency. The company's solutions cater to smart factories, smart cities, robotics, AI computing, AI networking, and smart cameras, enabling real-time processing and automation across industries.
Key facts about DeepX
- Founded Year: 2018
- Location: Seongnam-si (South Korea)
- Annual Revenue: $0 - $1M as on Dec 31, 2023
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $132M
- Employee Count: 217 as on Jul 31, 2026
- Investors: Magna, Korea Development Bank Europe and 12 Others
- Latest Funding Round: Series D, Aug 03, 2026, $*****
- Highlight: Editors' Pick
Standard Energy specializes in developing redox flow batteries. The batteries are equipped with electrolyte circulation technology and do not consist of a conventional pump system. Also, the batteries are made with thin composite materials with a cell stacking technology to prevent the systems from energy loss.
Key facts about Standard Energy
- Founded Year: 2013
- Location: Yuseong District (South Korea)
- Stage: Series D
- Total Funding till date: $76.7M
- Employee Count: 64 as on Jul 31, 2026
- Investors: SBVA, Magna and 5 Others
- Latest Funding Round: Series D, Jan 06, 2022, $*****
- Highlight: Editors' Pick
_1579153113195.png?format=webp&height=120&width=120){kind=logo}
5. Oncocross
Oncross is an AI-based drug discovery platform. The platform helps in matching and reporting of drugs, the user put data of the and then through AI the software gives matching and reporting of the drug interaction.
Key facts about Oncocross
- Founded Year: 2015
- Location: Seoul (South Korea)
- Stage: Public
- Total Funding till date: $13.9M
- Employee Count: 18 as on Jul 31, 2026
- Investors: Magna, KB Securities and 11 Others
- Latest Funding Round: Series B, Sep 10, 2020, $*****
- Highlight: Public
Magna's Year-on-Year Investment Trends
Magna has invested in 56 companies over the last 8 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 1 investment, while as of Aug 2026, it has made 2 investments in this year. Its most recent first time investment was in ABLE Labs and most recent follow-on round was in Featuring.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 1 | 0 | 1 |
2024 | 3 | 0 | 3 |
2023 | 1 | 1 | 2 |
2022 | 3 | 0 | 3 |
2021 | 1 | 3 | 4 |
2020 | 2 | 0 | 2 |
2019 | 3 | 0 | 3 |
2018 | 2 | 0 | 2 |
Magna's Investments by Stage
Magna has made 9 investments in Series A stage with an average round size of $5.68M, 5 investments in Seed stage with an average round size of $2.44M and 3 investments in Series B stage with an average round size of $56.3M.Stage of entry | No. of Investments |
|---|---|
Series A | 9 |
Seed | 5 |
Series B | 3 |
Note: We have considered here, only first round of investments
Magna's Investments by Sector
Magna has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, Business Services, Life Sciences and Food and Agriculture Tech. Notably, it has invested in 35 Tech companies, 34 Enterprise (B2B) companies, 17 Software companies and at least 9 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Enterprise Applications | 6 |
High Tech | 5 |
Business Services | 3 |
Life Sciences | 3 |
Food and Agriculture Tech | 2 |
Others | 15 |
Note: We have considered here, only first round of investments
Magna's Investments by Geography
Magna has made most investments in South Korea (17).Magna's recent investments
Magna has made 2 investments in 2026 so far - ABLE Labs and Featuring.Here are the most recent investments by Magna:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Aug 31, 2026 | South Korea | Series A | 3662 | ||
May 19, 2026 | South Korea | Series B | 9546 | [+5] | |
Jun 16, 2025 | South Korea | Series A | 7603 | [+1] | |
Jul 16, 2024 | South Korea | Seed | 4329 | ||
Jul 02, 2024 | South Korea | Seed | 8420 | [+2] |
IPOs and Publicly Listed companies in Magna's Portfolio
22 of Magna's portfolio companies have become public. Oncocross got listed on the Korea Exchange (KRX), in Dec 2024 at marketcap of $59.6M and 3billion got listed on the Korea Exchange (KRX) at marketcap of $101M.Here are Magna's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 18, 2024 | - | - | 9759 | |
Nov 14, 2024 | Oct 07, 2019 | Series B | 5091 | |
May 02, 2024 | Aug 14, 2019 | Series B | 2090 | |
Dec 05, 2023 | - | - | 6434 | |
Jul 26, 2023 | Sep 18, 2019 | Series A | 8955 |
_1579153113195.png?devicePixelRatio=2&height=20&width=20){kind=logo}
_1556001223538.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Acquired companies in Magna's Portfolio
2 companies from Magna's portfolio have been acquired. The most recent acquisition was Anygen in Mar 2025 by HLB for $*****.Here are Magna's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 11, 2025 | - | - | 4675 | |
Jun 01, 2017 | - | - | 9798 |
Team profile of Magna
Magna has a team of 10 members including 5 Partners and 5 Principals located in South Korea. Magna's team does not sit on the board of any company as of now.Here is a list of all team members in Magna:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | South Korea | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Principal | - | - | - | |
Principal | - | - | - | |
Principal | - | - | - | |
Principal | - | - | - | |
Principal | - | - | - |
Co-investors of Magna
Over the past 8 years, 102 investors have co-invested in Magna's portfolio companies. This includes funds and angels.
- Invested before Magna: SparkLabs, The Wells Investment and 14 others have invested in rounds before Magna. There are 2 companies where SparkLabs has invested before Magna and 1 company where The Wells Investment has invested before Magna.
- Top Co-investors of Magna: 50 investors entered a company along with Magna. These include investors like Shinhan Financial Group (3 companies).
- Invested after Magna: A total of 36 investors have invested in Magna's portfolio after their investments. Top Investors include DS (2 companies), Korea Development Bank Europe (2 companies) and Industrial Bank of Korea (2 companies).
Recent News related to Magna
•
Construction Equipment Electrification 'Elect' Attracts Pre-Series A InvestmentWowtale•Jul 16, 2024•KR Electric, Magna, The Invention Lab, ELLECT and 1 other
•
B2B SaaS 'CastingN' Attracts 5.2 Billion Won in Series B Investment Cumulative Investment Surpasses 15 Billion WonWowtale•Jul 08, 2024•CastingN, Magna, PKSHA Technology, Pathfinder H and 5 others
•
Online study assistant operator Bebridge receives $1.9 mn in pre-Series AKedglobal•Jul 21, 2022•BeBridge, Magna, BluePoint Partners, DT&Investment and 2 others
•
•
S Korea’s D&D Pharmatech raises $137m led by Octave Life Sciences, othersDeal Street Asia•Aug 16, 2019•D&D Pharmatech, Smile Gate Investment, MAGNA Investment, LB Investment and 3 others
